These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21076473)

  • 1. Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes.
    Tabariès S; Dong Z; Annis MG; Omeroglu A; Pepin F; Ouellet V; Russo C; Hassanain M; Metrakos P; Diaz Z; Basik M; Bertos N; Park M; Guettier C; Adam R; Hallett M; Siegel PM
    Oncogene; 2011 Mar; 30(11):1318-28. PubMed ID: 21076473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudin-16 reduces the aggressive behavior of human breast cancer cells.
    Martin TA; Harrison GM; Watkins G; Jiang WG
    J Cell Biochem; 2008 Sep; 105(1):41-52. PubMed ID: 18442037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical modulation of VLA integrin affinity in human breast cancer cells.
    Pec MK; Artwohl M; Fernández JJ; Souto ML; Alvarez de la Rosa D; Giraldez T; Valenzuela-Fernández A; Díaz-González F
    Exp Cell Res; 2007 Apr; 313(6):1121-34. PubMed ID: 17331499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells.
    Jia Y; Zeng ZZ; Markwart SM; Rockwood KF; Ignatoski KM; Ethier SP; Livant DL
    Cancer Res; 2004 Dec; 64(23):8674-81. PubMed ID: 15574776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components.
    van der Pluijm ; Vloedgraven H; Papapoulos S; Löwick C; Grzesik W; Kerr J; Robey PG
    Lab Invest; 1997 Dec; 77(6):665-75. PubMed ID: 9426405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
    Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
    J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoactivin promotes breast cancer metastasis to bone.
    Rose AA; Pepin F; Russo C; Abou Khalil JE; Hallett M; Siegel PM
    Mol Cancer Res; 2007 Oct; 5(10):1001-14. PubMed ID: 17951401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Different integrin-induced adhesion of highly liver metastatic and little metastatic colon carcinoma cells in an extracellular matrix].
    Haier J; Nasralla M; Buhr HJ; Nicolson GL
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):307-13. PubMed ID: 14518266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes.
    Tabariès S; Dupuy F; Dong Z; Monast A; Annis MG; Spicer J; Ferri LE; Omeroglu A; Basik M; Amir E; Clemons M; Siegel PM
    Mol Cell Biol; 2012 Aug; 32(15):2979-91. PubMed ID: 22645303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin expression on normal and neoplastic human breast epithelium.
    Damjanovich L; Fülöp B; Adány R; Nemes Z
    Acta Chir Hung; 1997; 36(1-4):69-71. PubMed ID: 9408292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol alters the interaction of glycosphingolipid GM3 with alpha5beta1 integrin and increases integrin-mediated cell adhesion to fibronectin.
    Gopalakrishna P; Rangaraj N; Pande G
    Exp Cell Res; 2004 Oct; 300(1):43-53. PubMed ID: 15383313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin expression and function on human osteoblast-like cells.
    Gronthos S; Stewart K; Graves SE; Hay S; Simmons PJ
    J Bone Miner Res; 1997 Aug; 12(8):1189-97. PubMed ID: 9258748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
    Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of integrins with adhesion-promoting, heparin-binding peptides of type IV collagen in cultured human corneal epithelial cells.
    Maldonado BA; Furcht LT
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):364-72. PubMed ID: 7843907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different adhesion properties of highly and poorly metastatic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components.
    Haier J; Nasralla M; Nicolson GL
    Br J Cancer; 1999 Aug; 80(12):1867-74. PubMed ID: 10471033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered gene expression in breast cancer liver metastases.
    Erin N; Wang N; Xin P; Bui V; Weisz J; Barkan GA; Zhao W; Shearer D; Clawson GA
    Int J Cancer; 2009 Apr; 124(7):1503-16. PubMed ID: 19117052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells.
    Borrirukwanit K; Lafleur MA; Mercuri FA; Blick T; Price JT; Fridman R; Pereira JJ; Leardkamonkarn V; Thompson EW
    Matrix Biol; 2007 May; 26(4):291-305. PubMed ID: 17175151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors.
    Droz D; Patey N; Paraf F; Chrétien Y; Gogusev J
    Lab Invest; 1994 Nov; 71(5):710-8. PubMed ID: 7526040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of Claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease.
    Sauer T; Pedersen MK; Ebeltoft K; Naess O
    Cytopathology; 2005 Aug; 16(4):193-8. PubMed ID: 16048505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivation.
    Chen Q; Meng LH; Zhu CH; Lin LP; Lu H; Ding J
    Int J Biochem Cell Biol; 2008; 40(10):2164-73. PubMed ID: 18387333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.